LPL Financial’s Avidity Biosciences RNAM Stock Holding History

LPL Financial’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,614	Closed	-$621K	–	6133
2025 Q4	$621K	Sell	8,614 -8,778	-50%	-$567K	﹤0.01%	4522
2025 Q3	$758K	Buy	17,392 +4,969	+40%	+$201K	﹤0.01%	4273
2025 Q2	$353K	Sell	12,423 -1,623	-12%	-$48.4K	﹤0.01%	4658
2025 Q1	$415K	Sell	14,046 -2,680	-16%	-$83.5K	﹤0.01%	4335
2024 Q4	$486K	Buy	16,726 +12,253	+274%	+$512K	﹤0.01%	4115
2024 Q3	$205K	Buy	+4,473	New	+$194K	﹤0.01%	4709

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

LPL Financial's RNAM Position: Q1 2026 in Review

LPL Financial sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 8,614 shares — an estimated $621K sold.

LPL Financial first reported a position in RNAM in Q3 2024 and held it in 6 quarters. The position peaked at $758K in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

LPL Financial reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
LPL Financial sold 8,614 Avidity Biosciences shares in Q1 2026, an estimated $621K.
LPL Financial first reported a position in Avidity Biosciences in Q3 2024 and held it in 6 quarters.
LPL Financial's Avidity Biosciences position peaked at $758K in Q3 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.